Prosecution Insights
Last updated: October 02, 2026
Application No. 18/545,067

FILLABLE MEDICAMENT DELIVERY DEVICE

Non-Final OA §102
Filed
Dec 19, 2023
Examiner
RODRIGUEZ, CRIS LOIREN
Art Unit
3783
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Becton, Dickinson and Company
OA Round
2 (Non-Final)
26%
Grant Probability
At Risk
2-3
OA Rounds
6m
Est. Remaining
38%
With Interview

Examiner Intelligence

Grants only 26% of cases
26%
Career Allowance Rate
54 granted / 205 resolved
-43.7% vs TC avg
Moderate +11% lift
Without
With
+11.4%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
27 currently pending
Career history
224
Total Applications
across all art units

Statute-Specific Performance

§101
1.6%
-38.4% vs TC avg
§103
46.4%
+6.4% vs TC avg
§102
24.8%
-15.2% vs TC avg
§112
24.2%
-15.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 205 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Arguments Applicant’s arguments filed with respect to the rejection of claims 1-12 and 17-20 under Kriesel et al (US 20060195057) have been fully considered and are persuasive. Therefore, the rejection has been withdrawn. However, upon further consideration, a new ground(s) of rejection is made in view of Kim et al (KR 20220032385 A). Claim Objections Claim 1 is objected to because of the following informalities: Line 8, “has a face” should be replaced with “have a face”. Line 9, “the face has” should be replaced with “the faces have”. Appropriate correction is required. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim 17 is rejected under 35 U.S.C. 102(a)(1) as being anticipated by Kim et al (KR 20220032385 A). Regarding claim 17, Kim discloses a filable medicament delivery device, comprising: a body 200; a reservoir 210 disposed on the body and having an end wall with input 210I and output ports 210E disposed therethrough; a plunger 230 movably disposed within the reservoir; and a patient cannula N fluidly connected with the output port, wherein the end wall has a channel 211 recessed from an interior surface thereof, the channel fluidly connecting the input port and the output port through 212-213. Allowable Subject Matter Claims 2-16 and 21 allowed over the prior art of record. Claim 1 is objected. Claims 18-20 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. See PTO-892 form. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Cris L Rodriguez whose telephone number is (571)272-4964. The examiner can normally be reached Monday-Thursday 8am- 2pm.. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Chelsea Stinson can be reached at 571-270-1744. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /Cris L. Rodriguez/ Primary Patent Examiner Art Unit 3783
Read full office action

Prosecution Timeline

Dec 19, 2023
Application Filed
Apr 28, 2026
Non-Final Rejection mailed — §102
Jul 28, 2026
Response Filed
Aug 27, 2026
Non-Final Rejection mailed — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12746380
POWER SUPPLY DEVICE AND MEDICAL DEVICE
3y 9m to grant Granted Sep 29, 2026
Patent 12746592
NEEDLE BENDING DEVICE
3y 6m to grant Granted Sep 29, 2026
Patent 12734308
MEDICAL NEEDLE UNIT WITH AIR FILTER PART FOR PREVENTING AIR INJECTION
3y 2m to grant Granted Sep 15, 2026
Patent 12734289
DRUG DELIVERY DEVICE DRIVE SENSOR
2y 9m to grant Granted Sep 15, 2026
Patent 12728195
DEVICE FOR ADMINISTERING MEDICAL LIQUID, HAVING A HEAT SINK WITH COOLING FINS
3y 9m to grant Granted Sep 08, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

2-3
Expected OA Rounds
26%
Grant Probability
38%
With Interview (+11.4%)
3y 4m (~6m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 205 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month